Rare diseases
Investigational molecules
Locations
Spironolactone with drug combination to improve health in adults with Fontan circulation (clinical trial)
BelgiumA study to compare the effects of BI 690517 and spironolactone on kidney function in patients with heart failure, cardiovascular disease, or chronic kidney disease
The NetherlandsA Study Testing Drug Combination for Heart Failure in Women Comparing Increased Doses to Standard Care
ItalyA study testing the reduction of heart failure drug combination in patients with heart failure in remission
BelgiumStudy of Optimal Treatment for Uncontrolled Hypertension Using Triple Drug Combinations (Olmesartan/Amlodipine/Hydrochlorothiazide or Perindopril/Indapamide/Amlodipine) with Additional Diuretics
PolandStudy on Optimizing Treatment for Chronic Heart Failure with Reduced Ejection Fraction Using Nebivolol and a Drug Combination
CzechiaComparing Spironolactone and Eplerenone for Patients with Heart Failure and Reduced Ejection Fraction
DenmarkStudy on Spironolactone for Patients with Arrhythmogenic Right Ventricular Dysplasia (ARVD)
FranceStudy of spironolactone and Dihydralazine for reducing heart muscle scarring in patients with severe aortic valve narrowing after valve replacement procedure
GermanyStudy on Spironolactone for Treating Active Rheumatoid Arthritis in Patients
FranceStudy on the Effects of Spironolactone, Pioglitazone, and Metformin for Adolescent Girls and Young Women with Polycystic Ovary Syndrome (PCOS)
AustriaStudy on Slowing Advanced Puberty in Girls Using Metformin, Pioglitazone, and Spironolactone
SpainTell us about your condition – we search every trial in Europe and connect you with the right site.
